| Bicalutamide studied in …STUDIED_INderived138 of 138show fewer |
|---|
| → studied in | NCT02531516Phase 3 · active not recruiting An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07593079Phase 2 · not yet recruiting Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783282Phase 1 · not yet recruiting A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455903Phase 2 · recruiting Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605486Phase 1/Phase 2 · active not recruiting Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521698Phase 1 · recruiting A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · 138 trials list this drug (27 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251861Phase 2 · completed Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544830Phase 2 · active not recruiting Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03650894Phase 2 · active not recruiting Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients · 138 trials list this drug (27 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095207Phase 1/Phase 2 · recruiting Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer · 138 trials list this drug (27 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06365788Phase 2 · recruiting Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer · 138 trials list this drug (27 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936390Phase 3 · completed Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04943536Phase 1 · active not recruiting Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06650579Phase 3 · recruiting REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734730Phase 2 · recruiting Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090165Phase 1/Phase 2 · active not recruiting Ribociclib and Bicalutamide in AR+ TNBC · 138 trials list this drug (27 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01809691Phase 3 · completed S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03809000Phase 2 · active not recruiting A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327647Phase 2 · recruiting A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer · 138 trials list this drug (27 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04025372Phase 2 · active not recruiting INTREPId (INTermediate Risk Erection PreservatIon Trial) · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034095completed A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528210Phase 2 · withdrawn Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06501911Phase 1 · withdrawn A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma · 138 trials list this drug (27 active) | — | — | Glioblastoma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342367NA · active not recruiting Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05513365Phase 2 · recruiting Phase II Dutasteride in Combination With CAB vs CAB in SDC · 138 trials list this drug (27 active) | — | — | Salivary Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299999Phase 2 · active not recruiting SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01288911Phase 2 · completed A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141671Phase 2 · unknown Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03358563early Phase 1 · completed Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 138 trials list this drug (27 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06018116Phase 2 · withdrawn A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. · 138 trials list this drug (27 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099086Phase 1 · completed Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482807Phase 1 · completed Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541047Phase 3 · completed RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00651326Phase 3 · terminated Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771017Phase 2 · withdrawn Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02058706Phase 2 · completed LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019846Phase 3 · recruiting SRT Versus SRT+ADT in Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043807Phase 2 · completed A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055731Phase 3 · completed Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004124Phase 3 · completed S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647356NA · unknown The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2 · 138 trials list this drug (27 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02064036Phase 1 · completed Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716974Phase 2 · completed A Study of Definitive Therapy to Treat Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00468715Phase 2 · completed Bicalutamide in Treating Patients With Metastatic Breast Cancer · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02582749Phase 2 · terminated Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002874Phase 3 · completed Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005044Phase 3 · completed Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05087706unknown Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS） · 138 trials list this drug (27 active) | — | — | Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003653Phase 3 · completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541928Phase 2 · recruiting Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520478Phase 3 · unknown A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055312Phase 3 · terminated Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer · 138 trials list this drug (27 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004054Phase 3 · completed Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023829Phase 3 · completed Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030654Phase 3 · completed Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059213Phase 2 · completed A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742675Phase 2 · unknown Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002633Phase 3 · completed Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02697032Phase 2 · completed FDHT PET and Bicalutamide in Metastatic Breast Cancer · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085252Phase 3 · completed A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00528866Phase 2 · completed Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664923Phase 2 · completed Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147196Phase 2 · withdrawn Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002855Phase 3 · completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165399Phase 2 · completed Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120236Phase 2 · completed Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878436Phase 1/Phase 2 · completed Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02348281Phase 2 · terminated Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814788Phase 2 · completed Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02910050Phase 2 · unknown Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer · 138 trials list this drug (27 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630344Phase 2 · completed RAD001 and Bicalutamide for Androgen Independent Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01200810Phase 2 · terminated Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589472Phase 2 · completed Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605226NA · unknown Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02615223NA · unknown Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658697Phase 2 · completed Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486642Phase 2 · completed Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy · 138 trials list this drug (27 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00170157Phase 2 · completed Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002651Phase 3 · completed SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769795Phase 2 · completed Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01050842early Phase 1 · completed Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470834Phase 4 · completed Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659438Phase 2 · completed Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00776594Phase 2 · completed Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021450Phase 3 · completed Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658527Phase 2 · withdrawn TAK-700 in Castration Resistant Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943956Phase 1 · completed Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243646Phase 3 · terminated Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586898Phase 2 · completed Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle · 138 trials list this drug (27 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00521781Phase 2 · terminated Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00067015Phase 3 · completed Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674270Phase 2 · completed Degarelix Neo-Adjuvant Radical Prostatectomy Trial · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00108732Phase 2 · completed A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02382094Phase 3 · completed Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02353988Phase 2 · unknown AR-inhibitor Bicalutamide in Treating Patients With TNBC · 138 trials list this drug (27 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00631527Phase 1 · completed Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00846976Phase 3 · completed Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666666Phase 2 · completed R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01020305Phase 1/Phase 2 · terminated Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01250717Phase 2 · completed Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086736Phase 2 · completed Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884273Phase 3 · completed Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831233Phase 3 · terminated Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00348998Phase 2 · unknown Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514917Phase 3 · terminated A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026377Phase 1 · completed SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00685633Phase 2 · withdrawn Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028769Phase 2 · completed S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003517Phase 2 · withdrawn Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012090Phase 2 · completed Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum · 138 trials list this drug (27 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00757692Phase 2 · completed Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512668Phase 1 · terminated Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684905Phase 2 · completed Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00833248Phase 3 · completed Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014586Phase 3 · terminated Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388804Phase 3 · terminated External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003026Phase 3 · completed Hormone Therapy in Treating Patients With Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00657904Phase 3 · completed Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer · 138 trials list this drug (27 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244920Phase 2 · withdrawn Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00233610Phase 3 · completed Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00637871Phase 2 · completed Casodex - Nolvadex Combination · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673205Phase 3 · completed (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer · 138 trials list this drug (27 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00672282Phase 3 · completed Casodex vs Placebo in Non-Metastatic Early Prostate Cancer · 138 trials list this drug (27 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00636259no longer available Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00590213Phase 4 · completed Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551044NA · completed Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer · 138 trials list this drug (27 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00418080Phase 2 · completed Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00421694Phase 2/Phase 3 · completed Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255268Phase 4 · withdrawn CMAB vs IMAB in Metastatic Prostate Cancer · 138 trials list this drug (27 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |